Cell Medica Stengthens Team with Key Appointments to Senior Management
12/22/2009 8:42:13 AM
LONDON--(BUSINESS WIRE)--Cell Medica, a clinical stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease and cancer, has announced that is has appointed four key staff to drive forwards the Company’s activities in the commercialisation of cell therapy treatments. The appointments will enable the Company to achieve scale up of its cell manufacturing operations, increase its clinical development capabilities and create a US presence with the appointment of a Head of US Operations.
comments powered by